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New Horizons in Supporting Older People’s Health and Wellbeing: Is Social 
Prescribing a Way Forward? 
 
Abstract: 
Older people’s health and care needs are changing. Increasing numbers live with the 
combined effects of age-related chronic illness or disability, social isolation and/or poor 
mental health. Social prescribing has potential to benefit older people by helping those with 
social, emotional or practical needs to access relevant services and resources within the local 
community. However, researchers have highlighted limitations with the existing evidence-
base, while clinicians express concerns about the quality of onward referral services, liability 
and upfront investment required. The current article provides a critical review of evidence on 
social prescribing, drawing on the RE-AIM Framework (Glasgow et al., 1999) to identify 
questions that will need to be addressed in order to inform both the design and delivery of 
services and the evolving research agenda around social prescribing. We emphasise the need 
for researchers and planners to work together to develop a more robust evidence-base, 
advancing understanding of the impacts of social prescribing (on individuals, services and 
communities), factors associated with variation in outcomes and strategies needed to 
implement effective and sustainable programmes. We also call on policymakers to recognise 
the need for investment in allied initiatives to address barriers to engagement in social 
prescribing programmes, provide targeted support for carers and improve access to older 
adult mental health services. We conclude that social prescribing has potential to support 
older people’s health and wellbeing, but this potential will only be realised through strategic 






The aim of this review is to consider the potential role of social prescribing in supporting 
older people’s health and wellbeing. We begin by summarising sociodemographic trends 
relevant to understanding older people’s changing health and care needs. The concept of 
social prescribing is then considered, from both a policy and research perspective, as we 
examine how it is implemented in practice and to what extent services are underpinned by 
evidence. Implications for the design and delivery of services and the research agenda around 




It is estimated that the world’s population aged 60 years and older will reach 2 billion by 
2050, an increase from 900 million in 2015 [1]. Population aging is associated with 
increasingly complex health care needs – as people age, there is a trend towards declining 
physical and mental capacity and rising prevalence of chronic conditions such as 
osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, and dementia. 
People are also more likely to experience several conditions at the same time [1]. Healthcare 
needs among older people are characterised by considerable variability, with some 80 year 
olds having physical and mental capacities similar to many 20 year olds and others 
experiencing significant declines at much younger ages [1]. 
Research further highlights rising levels of social isolation and loneliness among older 
people. Prevalence of isolation is around 13-15% among those aged 65 or over [2], higher for 
those aged 80 or over and much higher in deprived inner-city/ inaccessible rural areas [3]. 
Paradoxically, as a result of feeling trapped at home many older people find it difficult to 
 
 
make connections that could reduce their sense of isolation [4]. Surveys have consistently 
revealed that 6-13% of older people report they are often or always lonely [5,6]. Loneliness, 
especially persistent loneliness, is associated with increased vulnerability to mental health 
problems, particularly depression and risk of suicide [7]. 
The concept of resilience has been used to understand risk and protective factors associated 
with individual variability in health and wellbeing among older people. Wild et al. [8] view 
resilience as the product of a number of separate but linked areas: psychological, mobility, 
financial, environmental, physical, social and cultural. An individual may be resilient in one 
area (e.g. income), but not another (e.g. physical health); this balance may vary over time and 
in response to changing circumstances. The Age UK report Improving Later Life [9] 
conceptualises resilience as having three legs: wealth, health, and social networks and 
support. The report acknowledges that resilience is broader than an individual trait and that 
the system around the older person - family, universal services, the environment and care 
services - plays a key role in facilitating and supporting resilience.  The Age Concern and 
Mental Health Foundation inquiry into Mental Health and Wellbeing in Later Life [10] 
highlighted five key foci for policy and public investment: maintaining relationships; 
participation in meaningful activity; physical health; discrimination; and addressing poverty.  
What is Social Prescribing? 
Social prescribing involves the referral of patients with social, emotional or practical needs to 
non-clinical services and community-based resources. While this practice is not new, it has 
become more formalised in recent years, as health care systems (most notably, the UK 
National Health Service) have increasingly invested in social prescribing programmes or 
schemes (also called community referral or linking schemes). These typically involve the use 
of non-clinically trained link workers (also called connectors, health advisers, coordinators, 
 
 
care navigators, or community navigators) to assess patients’ support needs and help them 
engage with relevant services and activities [11,12]. These may include for example, benefits, 
housing or employment advice, bereavement support, health behaviour change programmes, 
or opportunities for arts, creative, or nature-based activities (e.g. community gardening, or 
green exercise initiatives). In 2017, there were more than 100 social prescribing schemes 
running in the UK [13] and a recent survey found that nearly a third of family doctors in the 
UK were using social prescribing [14]. There is also growing interest in this approach beyond 
the UK context, with examples of related initiatives in Ireland [15], the Netherlands [16], 
Scandinavia [17], the US [18], Canada [19] and Australia [20]. 
How Does Social Prescribing Fit with Health and Social Care Policy? 
Increasing investment in social prescribing in the UK reflects the national policy agenda. 
Social prescribing is recommended one of ‘10 High Impact Actions’ to increase capacity in 
general practice and reduce physician workload [21]. The NHS Long Term Plan [22] includes 
a commitment to increase access to social prescribing across England as part of a 
personalised care model. This includes ensuring that over 1,000 trained link workers are in 
place by the end of 2020/2021. The Health and Wellbeing Fund is investing £4.5 million in 
23 social prescribing projects across England to extend existing schemes or establish new 
ones. The aim is to improve patients’ quality of life, health and wellbeing and reduce demand 
on health services [23]. 
Social prescribing initiatives are also highlighted in a 2017 report of the UK Government’s 
All Party Parliamentary Group on Arts Health and Wellbeing [24]. Benefits cited include: 
strengthening preventative strategies to maintain health for all; helping frail and older people  
stay healthy and independent; enabling patients to take a more active role in their own health; 
improving recovery from illness; enhancing mental health and social care; mitigating social 
 
 
isolation and loneliness, strengthening local services and promoting more cohesive 
communities; enabling more cost-effective use of healthcare resources; relieving pressure on 
primary care and increasing health and social care staff wellbeing.  
Prescribing nature-based health promotion activities and ‘green care’ services is consistent 
with the Natural Environment White Paper The Natural Choice: securing the value of nature 
which identifies a need to strengthen the connection between people and nature [25]. A 
commissioned report by Natural England [26] concluded that there is strong evidence of the 
efficacy of nature-based interventions and these are welcomed by patients and clinicians. 
The development of social prescribing initiatives beyond the UK context reflects similar 
policy drivers. Alderwick et al. [18] emphasise that although the UK and US have very 
different healthcare systems, a variety of policy initiatives in both counties, such as 
accountable care organisations and other value-based payment models, have created 
opportunities for approaches such as social prescribing to be developed within the healthcare 
system - models that reward outcomes of care, rather than just provision of services also offer 
incentives for providers to address psychosocial factors that impact health. Keenaghan et al. 
[15] report that development of social prescribing in Ireland is underpinned by policy 
emphasis on the importance of a comprehensive community level response for people with 
mental health difficulties, including non-medical interventions at primary care level. In the 
Netherlands, Canada and Australia, social prescribing is similarly viewed as a means of 
offering patients a wider range of options, reducing reliance on medical interventions and 
more effectively targeting social factors influencing health and wellbeing [16,19,20]. In 
Scandinavian countries (particularly in Sweden), policy emphasis on the importance of arts 




How is Social Prescribing Implemented in Practice? 
Most social prescribing programmes have developed in response to local need rather than 
being systematically planned, resulting in a variety of practice [12, 27]. Referrals are 
commonly made by family doctors, although some programmes accept referrals from allied 
health professionals, nurse specialists or consultants (particularly for cancer patients). Link 
workers may be based in medical centres, or community settings and there is significant 
variability in link worker skills, knowledge and training [12, 27]. A variety of mechanisms 
exist for targeting and identifying patients ‘in need’ of social prescribing. In some areas, a 
risk stratification model is used to identify patients based on their level of clinical need, while 
others rely on less formal needs assessments and clinician discretion [28]. 
Social prescribing programmes are highly heterogeneous in terms of both the target patient 
group and the services offered (which often include small voluntary, or community groups 
operating at a local level) [27]. For example, the Bromley-by-Bow Centre in London, 
England, one of the oldest social prescribing schemes, helps patients to engage in services 
and activities ranging from gardening to housing and benefits advice. The scheme is available 
to patients aged 18 or over, registered with participating practices. A parallel example in the 
US is Health Leads, a non-profit organisation that trains and supervises volunteers to help 
patients identify support needs (including employment, housing, legal and other needs) and 
navigate relevant community-based resources - patients are screened during regular clinic 
visits [18]. 
Other schemes target specific groups, including older people, people with mental health 
needs, learning disabilities, diabetes, obesity or chronic pain. These adopt a variety of 
models, including Arts on Prescription Programmes (which refer patients to arts in the 
community, including museums, galleries and libraries), Books on Prescription 
 
 
(Bibliotherapy), Education on Prescription and Exercise on Prescription (Exercise Referral) 
[15, 17, 29].  
What Evidence is there that Social Prescribing is Effective? 
Despite widespread enthusiasm for social prescribing, evidence of effectiveness is limited. A 
systematic review [27] identified that most evaluations are small scale and hampered by poor 
design and reporting. Missing information made it difficult to assess who received what, for 
what duration, with what effect and at what cost. The reviewers concluded that ‘there is an 
urgent need to improve the ways by which schemes are evaluated’ (p15). 
Researchers have further highlighted problems with assumptions underlying social 
prescribing [30], including that voluntary and community services can be readily 
incorporated into formal care pathways. There is often no direct funding for the 
services/activities patients are offered via social prescribing and these may lack specific 
inclusion criteria, or accreditation requirements for the service provider. Consequently, 
clinicians have expressed concerns about the quality of services and their liability when 
referring patients to social prescribing schemes [14, 26]. Also, while social prescribing 
initiatives may reduce primary care workloads over the longer term, physicians have 
questioned the level of upfront investment and workload required to implement these 
properly at the start [14]. In the UK, the Royal College of General Practitioners has argued 
that for social prescribing to effectively link patients with local services, funding and support 
is required to enable these to be accessible and sustainable [14]. Alderwick et al. [18] report 
that in both the UK and US, efforts to incorporate social supports under alternative payment 
models and allow funding to ‘follow the patient’ could present new opportunities for 
integrated care delivery. 
 
 
Researchers have additionally noted the impact of cuts to other services, such as reductions in 
mental health services resulting in inappropriate referrals to social prescribing programmes, 
requiring link workers to provide support beyond their skills and training [31]. Alderwick et 
al [18] highlight that in both the UK and US, social services are under major financial strain, 
often struggling to meet community needs. In England, there have been significant cuts to 
welfare benefits and local services since 2010, as well as the reversal of policies aimed at 
reducing health inequalities. Consequently, increased referral to community services may 
have unintended consequences, placing services under greater strain and/or increasing 
patients’ frustration if resources are not available to meet their needs [18]. Focusing on the 
needs of socially isolated older people, a recent commentary in the British Medical Journal 
questioned whether social prescribing programmes are really what people want, or if funding 
would be better directed to sustaining local infrastructure such as bus services, libraries and 
public spaces, providing ‘natural’ opportunities for social activity and engagement [32]. 
Assumptions underlying social prescribing are highlighted in Figure 1. 
Figure 1. Some of the assumptions underlying social prescribing (from Hamilton-West et 
al. [30]) 
Assumption 1. Social prescribing is effective – there is sufficient high-quality research 
evidence to judge impacts on patient outcomes, health service costs and physician workload.  
Assumption 2. Social prescribing services are being implemented in ways that allow for 
evaluation - there is a clear underlying logic model and robust monitoring of inputs and 
outcomes (for patients, referrers and onward referral services).  
Assumption 3. Social prescribing is what patients want – patients have been involved in its 
development, and users’ experiences have been explored via qualitative research.  
 
 
Assumption 4. Social prescribing is what referrers want – SP services have been developed 
in collaboration with referring health professionals and referrers’ experiences have been 
explored via qualitative research.  
Assumption 5. Social prescribing works for onward referral services – small, community 
groups (often relying on volunteers) are willing and able to accept referrals and respond to 
people’s needs - and this is sustainable over the longer term.  
Assumption 6. We know what skills, competencies and resources link workers need in order 
to be person-centred and effective, and to manage risk appropriately.  
Assumption 7: There is a close match between services available in the local area and the 
needs of patients attending primary care – health professionals can be confident that an 
individual’s needs will be met via referral to social prescribing. 
How Might Social Prescribing Benefit Older People? 
There are few controlled studies examining social prescribing for older people. However, 
research has demonstrated positive impacts of engagement in gardening, nature-based 
activities, museum-based activities and creative arts among older people, including benefits 
for wellbeing, health and social isolation [33-35]. Service evaluations of social prescribing 
pilot projects targeting older people experiencing social isolation and mild-to-moderate 
mental health problems report benefits including increased self-esteem, improved mental 
wellbeing, reduced loneliness and reduced health service use [36-37]. A realist evaluation of 
a large social prescribing pilot project in London, England revealed that (predominantly older 
and social isolated) patients accessed a wide range of services and activities, including lunch 
clubs, walking groups, psychological counselling, gardening, and bereavement support. 
Empathetic support from social prescribing coordinators with a detailed knowledge of local 
 
 
services was a key mechanism enabling patients to act upon improving their own health and 
wellbeing [36]. 
Potential benefits of social prescribing for older people highlighted in policy documents and 
evaluations of local services are illustrated in Figure 2. Further research will be needed to 
develop a robust evidence-base in relation to each of these.  
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Implications for Social Prescribing Researchers and Planners 
To ensure that future design and implementation of social prescribing services is underpinned 
by evidence, researchers and planners will need to work together more closely, enabling 
programmes to be developed with a clear underlying logic model, describing the programme 
aims and assumptions, inputs (staff and resources), outputs (activities and participants) and 
outcomes (short, medium and long-term), as well as hypothesised relationships between 
these. The target group(s) also need defining. To allow for meaningful evaluation, planners 
must ensure that expected outcomes are plausible, measurable (on the basis of available data) 
and can be reliably attributed to the intervention [38].  
Further research is required to advance understanding of the strategies needed to implement 
social prescribing programmes at scale across diverse settings [38, 39]. Baker and Irving [40] 
suggest that successful implementation of social prescribing depends on the ability of 
multiple organizations, operating in different institutional fields and with different codes of 
practice, to co-produce a treatment and care regime through collaboration with one another 
and with patients. This is a complex ask. Focusing on a pilot programme in the North East of 
England targeted at older people with early onset dementia and depression, they illustrate 
some of the difficulties social prescribing programmes face navigating the institutional 
logistics, norms and values underpinning effective collaboration.  
The RE-AIM evaluation model [41] provides a useful framework for examining programmes 
across a number of key dimensions (Reach, Efficacy, Adoption, Implementation and 
Maintenance), which operate at multiple levels (e.g. individual, setting, organization, 
community) and interact to determine the public health or population-based impact of a 




Table 1. Priority Questions for SP Research Relating to REAIM Framework 
Dimensions 
Reach What proportion of the target population (e.g. older people with complex 
health and care needs) participate in social prescribing programmes 
when offered and why? To what extent is there a close match between 
activities/services offered and the needs and priorities of the target 
population? Which criteria determine whether referral to social 
prescribing is appropriate and what are the determinants of participation 
in activities offered? Are there potential barriers to participation (e.g. 
relating to chronic illness, disability, dementia/cognitive impairment, 
poor mental health, reduced mobility, poverty, discrimination, lack of 
transport)? If so, how could these be addressed?  
Efficacy Does social prescribing impact on outcomes relevant to the target 
population (e.g. those illustrated in Fig 2)? Are there any unanticipated 
negative outcomes for patients, staff (including referring clinicians, link 
workers and activity providers), or services (including primary and 
secondary care, social care, mental health, community and voluntary 
services)? If so, how could these be addressed? What knowledge, skills 
and competencies do staff (referring clinicians, link workers, activity 
providers) need to provide effective support for older people with 
complex health and care needs?  
Adoption What proportion of relevant settings (e.g. medical practices) 
deliver/engage in social prescribing programmes? What barriers are 
there to implementation (e.g. relating to institutional logistics, norms and 
 
 
values, clinician concerns about quality of onward referral services, 
liability and upfront investment required) and how could these be 
addressed?  Are there other services/professionals (e.g. mental health, 
social care, or emergency services) that could refer to social prescribing? 
What are the potential barriers and enablers to involving these 
organisations? What types of organisations accept referrals via social 
prescribing and why? What are the potential barriers and enablers for 
activity providers? 
Implementation To what extent are social prescribing programmes implemented as 
intended? Is there a clear underlying theory and logic model that is 
understood by all stakeholders (e.g. referring clinicians, link workers, 
activity providers)? Is this supported by appropriate staff training and 
supervision? Are there barriers preventing effective implementation at 
the individual, setting, or organisational levels? If so, how could these be 
addressed? 
Maintenance To what extent are social prescribing programmes sustained over time? 
What strategies are needed to maintain service quality and ensure staff 
knowledge, skills and competencies remain to date? Are there barriers to 
maintenance at the individual, setting, or organisational levels (e.g. 
relating to changes in: service user needs and priorities, service 
commissioning/funding, or onward referral services)? If so, how could 






Older people’s health and care needs are changing, as increasing numbers live with the 
combined effects of longstanding illness or disability, social isolation, loneliness and/or poor 
mental health. Social prescribing claims the potential to improve health and wellbeing by 
enabling those with social, emotional or practical needs to access relevant services and 
resources within the local community. It may also have the potential to improve the ‘system’ 
around the older person, by increasing capacity in primary care, delaying/preventing 
admission to hospital or nursing home and enabling a shift towards more holistic, person-
centred care. However, this potential is currently limited by a lack of robust evidence on 
either the impacts of social prescribing or the strategies necessary to implement effective and 
sustainable programmes.  
In this article, we propose a number of priority questions for future research, emphasising the 
need for social prescribing researchers and planners to work together more closely to ensure 
that the design and delivery of services is underpinned by robust evidence. Work to develop a 
standardized reporting template1 will also be important for improving the quality and 
completeness of social prescribing evaluation reporting and enhancing replication. However, 
some of the issues discussed extend beyond the remit of researchers and healthcare planners.  
For example, although it could be argued that social prescribing addresses some of the key 
areas for policy and public investment outlined in the Age Concern and Mental Health 
Foundation inquiry into Mental Health and Wellbeing in later life [10] (e.g. maintaining 
relationships, participation in meaningful activity, physical health), others seem less likely to 
be impacted by SP (e.g. poverty and discrimination). These factors could also make it more 
difficult for people to engage in social prescribing programmes. Hence, if social prescribing 





is implemented at scale without initiatives to address poverty and discrimination among older 
people, those at greatest risk of poor mental and physical health could be left behind. A 
related issue, is the lack of direct funding for onward referral services. If these are not funded 
as part of the implementation of social prescribing programmes, it is likely that either they 
will need to charge patients or the referral pathway will fail. The cost may be prohibitive for 
some patients and contribute to widening socioeconomic inequalities in health and wellbeing, 
a problem that may be compounded by lack of investment in public transport and community 
services and cuts to health and social care services.  
When considering the potential for social prescribing to provide a way forward for 
developing innovative support for older people, it is useful to differentiate between different 
levels of preventive activity. In relation to mental health, Goldie et al. [42] draw a distinction 
between primary prevention (intervening before a mental health problem arises – e.g. by 
reducing social isolation and loneliness), secondary prevention (identifying early signs of 
poor mental health and preventing more serious problems – e.g. via support for dementia 
carers with depression/ anxiety symptoms) and tertiary prevention (ensuring access to 
services and support for established mental health problems). It seems likely that social 
prescribing mainly operates at the level of primary prevention. To tackle the health and 
wellbeing challenges facing older people, investment in social prescribing programmes needs 
to complemented by investment in universally available/publicly funded secondary and 
tertiary prevention, such as carer support groups and older people’s mental health services. 
Conclusions 
We conclude that social prescribing has potential to support older people’s health and 
wellbeing and address difficulties at an early stage. However, this potential will only be 
realised if researchers and commissioners work together to address the questions highlighted 
 
 
here and if policy and investment is targeted towards enabling older people to access 
preventive services at primary, secondary and tertiary levels. 
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